Established in 1985, Jointown Pharmaceutical Group is a leading public listed company in Chinese pharmaceutical commercial industry, and it is the largest private pharmaceutical commercial enterprise in China with distribution mainly of western medicine, TCM and medical device to major clients including pharmaceutical institution, wholesaler enterprise and retail pharmacy, as well as to provide information, logistics and other value-added services to them. The headquarters is located in Wuhan of China with a total of 286 wholly-owned subsidiaries in 100% of the country's administrative regions. As of December 31, 2017, the Company realized revenue of RMB74 billion, and its registered capital has reached RMB1.64 billion and the total asset is RMB38.72 billion. The Company was listed on Shanghai Stock Exchange on November 2, 2010 (Stock name: Jointown, Stock code: 600998). There are more than 20,000 of employees in 2017.